View Clinical Trial (Medical Research Study)
Rollover Protocol for Prior SU011248 Protocols - NCT00798889-35294(Clinical Trial 255686)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Birmingham |
|
State:
|
|
AL |
| Zip Code: |
|
35294 |
| Conditions: |
|
Solid Tumour |
| Purpose: |
|
The objective of this protocol is to provide SU011248 treatment for patients who have
participated in a SU011248 protocol and are eligible to enter this protocol
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Prior SU011248 Protocol.
- Eligible to continue SU011248 treatment.
Exclusion Criteria:
- Uncontrolled CNS metastasis.
- Unfit to receive SU011248. |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
Birmingham, AL 35294
United States
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|